Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00512941
Status:
COMPLETED
Last Update Posted:
2008-09-05
First Post:
2007-08-06
Brief Title:
Laboratory Profile of Hepatitis B and C in Users of a Reference Service
Sponsor:
UPECLIN HC FM Botucatu Unesp
Organization:
UPECLIN HC FM Botucatu Unesp
Study Overview
Official Title:
Laboratory Profile of Hepatitis B and C in Users of a Reference Service
Status:
COMPLETED
Status Verified Date:
2008-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Chronic hepatitis by the B virus HBV andor by the C virus HCV is a major public-health problem since it presents a long phase of clinical latency which makes its early diagnosis difficult and results in the development of a large number of cases to complications such as cirrhosis hepatic insufficiency and hepatocarcinoma In Brazil it is estimated that the number of HBV is two million of which 72 thousand have been reported As regards HCV the ratio is one of three million estimated cases to 52 thousand reports Learning about the serological profile of the users of a viral hepatitis reference service is fundamental for the planning of diagnostic and caregiving actions therefore it is the objective of this study
Detailed Description:
Chronic hepatitis by virus B HVB andor by virus C HVC is a major public-health problem since it presents a long phase of clinical latency which makes its early diagnosis difficult and results in the development of a large number of cases to complications such as cirrhosis hepatic insufficiency and hepatocarcinoma In Brazil it is estimated that the number of HVB patients is two million but only 72 thousand have been reported As regards HVC the ratio is three million estimated cases to 52 thousand reports Learning about the serological profile of the users of a viral hepatitis reference service is essential for the planning of diagnostic and therapeutic actions therefore it is the objective of this study
Five hundred and thirty-one HVB and HVC serological profiles of the patients referred to SAEHD within a period of 18 months January 2006 to June 2007 were studied by means of retrospective analysis The patients were classified as a HBV carrier cure isolated anti-HBc and vaccinated b HVC reagent anti-HVC c HBVHVC co-infection AgHBs and reagent anti-HVC and d Susceptible non-reagent serology
As regards HBV the following were found from the total number of patients carriers 126 cure 189 isolated anti-HBc 90 and vaccinated 62 The patients with reagent anti-HVC comprised 313 of the total number of individuals HBVHCV co-infection was 06 Susceptible individuals comprised 205
It was concluded that approximately 45 of the referred patients carried chronic infection by B andor C virus a condition which requires additional investigation and in many instances specific treatment Strategies for early diagnosis are essential in order to prevent the intrinsic complications of such condition
Five hundred and thirty-one HVB and HVC serological profiles of the patients referred to SAEHD within a period of 18 months January 2006 to June 2007 were studied by means of retrospective analysis The patients were classified as a HBV carrier cure isolated anti-HBc and vaccinated b HVC reagent anti-HVC c HBVHVC co-infection AgHBs and reagent anti-HVC and d Susceptible non-reagent serology
As regards HBV the following were found from the total number of patients carriers 126 cure 189 isolated anti-HBc 90 and vaccinated 62 The patients with reagent anti-HVC comprised 313 of the total number of individuals HBVHCV co-infection was 06 Susceptible individuals comprised 205
It was concluded that approximately 45 of the referred patients carried chronic infection by B andor C virus a condition which requires additional investigation and in many instances specific treatment Strategies for early diagnosis are essential in order to prevent the intrinsic complications of such condition
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None